×
Any Patent Office
  • Any Patent Office
  • United States
  • Europe
  • International
  • China
  • Germany
  • Canada
Issued patents
Sorted by relevance
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The invention encompasses nucleic acid molecules containing transcription units which encode the flavivirus M and E protein antigens. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... be used as vaccines to prevent infection of RVF virus in livestock and humans. ... between vaccinated animals and animals infected with wild-type RVF virus. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
We have developed DNA and viral vectors that can be used, alone or in combination, as a vaccine against one HIV clade, subtype, or recombinant form of HIV ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Cited By (33). Publication number Priority date Publication date Assignee Title. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
US8420107B2 - Peptide vaccines against group A streptococci - Google Patents. Peptide vaccines against group A streptococci ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Also provided are vaccines comprising variants of M2 expressed in prokaryotic hosts. Further provided are methods of preventing influenza A infection using ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
A retrovirus and related method used in producing a model for evaluating the antiretroviral effects of drugs and vaccines includes the steps of removing ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The present invention encompasses isolated nucleic acids containing transcriptional units which encode a signal sequence of one flavivirus and an ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The present disclosure provides compositions and methods for eliciting an immune response against avian or pandemic influenza. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Vaccine compositions and methods of vaccinating a subject against rotavirus are provided which include generation and use of thermally inactivated ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Human monoclonal antibodies that specifically bind to rabies virus, antigen binding portions thereof, and methods of making and using such antibodies and ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... be used as vaccines to prevent infection of RVF virus in livestock and humans. ... between vaccinated animals and animals infected with wild-type RVF virus. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The disclosure further relates to vaccines comprising immunogenic compounds. ... Most HIV-1 vaccine constructs (DNA and recombinant protein vaccine) are ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Also provided are vaccines comprising variants of M2 expressed in prokaryotic hosts. ... influenza A infection using vaccines comprised of variants of M2. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The present disclosure also relates to vectors and vaccines for use in humans against infection and disease. The disclosure further relates to a variety of ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
A process for detecting Bordetella spp. nucleic acid in a biological sample includes producing an amplification product(s) by amplifying one or more ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Disclosed herein is a rapid and universal assay for the detection of antigen-specific antibodies in biological samples. The assay allows for the detection ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
For example, rabies vaccine viruses possessing an amino acid differing from Arg ... strain corresponding to the fixed vaccine of Evelyn-Rokitnicki-Abelseth ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Peptides or polypeptides encoded by the disclosed nucleotide sequences can be used for vaccines or to detect antibodies from a subject directed to the ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Human monoclonal antibodies that specifically bind to rabies virus, antigen binding portions thereof, and methods of making and using such antibodies and ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... and immunocontraceptive peptide-specific antibodies in vaccinated animals, and protect vaccinated animals against wild-type rabies virus challenge. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Also provided are vaccines that include at least one of these epitopes that when administered to a subject provide improved acquired immunity. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... 206010047461 Viral infection Diseases 0.000 description 1; 210000002845 Virion Anatomy 0.000 description 1; 229960001129 Yellow Fever Vaccine Drugs ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The invention also encompasses a vaccine whose active agent is the nucleic acid. The invention further encompasses the cultured host cells when they contain ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
For example, many patients can be immunized with an inhaled vaccine composition using the present disclosure without the need for needles or reloading of ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... 229950010342 uridine triphosphate Drugs 0.000 description 1; 229960005486 vaccines Drugs 0.000 description 1; 239000000304 virulence factors Substances ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Class 1 OMPs appear to be good candidates for vaccine studies since these proteins have ... Evaluation of various non-capsular antigens as potential vaccine ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... on PDK and sanitization on Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV1 strain. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The attenuated chimeric viruses are effective as immunogens or vaccines and may be combined in a pharmaceutical composition to confer simultaneous immunity ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... on PDK and sanitization on Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV1 strain. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... instant invention is also amenable to in vivo screening protocols for the discovery and development of anthrax vaccines and lethal factor inhibitors. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Holland Vaccine, Vaccinia virus ... Sheeppox Vaccine, Sheeppox virus ... the oral rabies vaccine (a live vaccinia-rabies glycoprotein recombinant virus) ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
In addition, immunogenic compositions, such as vaccines, that contain the ... In a vaccine composition, the synthetic peptide is preferably linked to a ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The present system can be used to administer various types of agents, such as a vaccine or other types of pharmaceutical substances. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
The aerosol containing an agent comprising, for example, a vaccine or other drug, is released from a source of aerosol 7 connected to the delivery inlet ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
For example, only a single vaccine or drug dose is administered using aerosol ... A preferred method comprises administration of a vaccine composition using ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
In addition, the need exists for vaccines for such viruses, for example by producing an immune response to peptides isolated from such viruses. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
For example, rabies vaccine viruses possessing an amino acid differing from Arg at position 333 of the glycoprotein are described, for instance, ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... 102000018568 Alpha-defensin Human genes 0.000 description 5; 108050007802 Alpha-defensin Proteins 0.000 description 5; 229960005447 Anthrax vaccines ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
One aspect of the invention relates to vaccines and methods for protecting canines from canine influenza, kits comprising such vaccines, and methods for ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... 230000035633 Metabolized Effects 0.000 description 1; 101710050072 Micrococcal Nuclease Proteins 0.000 description 1; 229940095293 Mumps Vaccine Drugs ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Currently, post-exposure prophylaxis includes thorough wound-washing with soap and water followed by administration of vaccine and anti-rabies virus ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Successful polysaccharide vaccines are available in the United States. However, countries with limited resources cannot afford these vaccines. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
A process for detecting human rhinovirus nucleic acid in a biological sample, includes producing an amplification product by amplifying an human bocavirus ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Pseudotyped retroviruses having viral glycoproteins with modified O glycosylation regions are provided. Also provided are methods for making the pseudotyped ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Various technologies are described by which the usable portion or threshold value of a sigmoid curve is found. Such techniques can be useful, for example, ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Additionally, the polypeptides are useful in pharmaceutical compositions such as vaccines to elicit an immune response in a subject. Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
... 229960005447 Anthrax vaccines Drugs 0.000 description 5; 108010060123 Conjugate Vaccines Proteins 0.000 description 5; 280000660386 Endogen, ... Overview · Related · Discuss
vaccine inassignee:centers inassignee:for inassignee:disease inassignee:control from www.google.de
Most human sera contain anti-DT neutralizing antibodies from childhood immunization. To compensate for this the therapeutic dose of anti-CD3-CRM9 can be ... Overview · Related · Discuss